Evolus, Inc.

Yield per half year: -4.56%
Dividend yield: 0%
Sector: Healthcare

Fair price Evolus, Inc.

Current price
6.9 $
Average price
5.37 $ -22.13%

Price based on EPS
8.91 $ +29.09%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 8.91 $
Current price = 6.9 $ (difference = +29.09%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = βˆ‘ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -1.47 $
Current price = 6.9 $ (difference = -121.29%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = βˆ‘ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -0.9487 $
Current price = 6.9 $ (difference = -113.75%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription